BeOne Medicines Ltd. (ONC)
361.17
+1.20
(+0.33%)
USD |
NASDAQ |
Sep 25, 16:00
361.17
0.00 (0.00%)
After-Hours: 17:53
BeOne Medicines Cash from Operations (TTM) : 1.488B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.488B |
| March 31, 2026 | 1.288B |
| December 31, 2025 | 1.131B |
| September 30, 2025 | 786.80M |
| June 30, 2025 | 571.97M |
| March 31, 2025 | 212.02M |
| December 31, 2024 | -140.63M |
| September 30, 2024 | -437.43M |
| June 30, 2024 | -703.95M |
| March 31, 2024 | -902.25M |
| December 31, 2023 | -1.157B |
| September 30, 2023 | -1.254B |
| June 30, 2023 | -1.738B |
| March 31, 2023 | -1.823B |
| December 31, 2022 | -1.496B |
| September 30, 2022 | -1.685B |
| June 30, 2022 | -1.621B |
| March 31, 2022 | -1.662B |
| December 31, 2021 | -1.300B |
| September 30, 2021 | -1.125B |
| Date | Value |
|---|---|
| June 30, 2021 | -973.75M |
| March 31, 2021 | -816.42M |
| December 31, 2020 | -1.283B |
| September 30, 2020 | -1.218B |
| June 30, 2020 | -1.137B |
| March 31, 2020 | -920.24M |
| December 31, 2019 | -750.27M |
| September 30, 2019 | -676.98M |
| June 30, 2019 | -544.16M |
| March 31, 2019 | -615.19M |
| December 31, 2018 | -547.72M |
| September 30, 2018 | -260.07M |
| June 30, 2018 | -121.29M |
| March 31, 2018 | -56.04M |
| December 31, 2017 | 12.75M |
| September 30, 2017 | -107.14M |
| June 30, 2017 | -138.01M |
| March 31, 2017 | -105.38M |
| December 31, 2016 | -89.51M |
| September 30, 2016 | -80.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Basilea Pharmaceutica AG | 75.01M |
| Santhera Pharmaceuticals Holding AG | -43.47M |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -369.58M |
| Idorsia Ltd. | -161.54M |